{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:02:03Z","timestamp":1790308923498,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Iron deficiency anemia (IDA) is common among obstetric and gynecologic patients. This systematic review aimed to assess the comparative efficacy and safety of commonly used intravenous (IV) iron formulations, ferric carboxymaltose (FCM), and iron sucrose (IS) in the treatment of IDA in obstetric and gynecologic patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We systematically searched PubMed, EMBASE, Cochrane CENTRAL, and Google Scholar for eligible randomized controlled trials (RCTs) comparing IV iron replacement using FCM and IS up to October 2019. The primary outcome was to compare the efficacy of FCM and IS, assessed by measuring serum hemoglobin (Hb) and ferritin levels before and after iron replacement. The secondary outcome was to compare the safety of FCM and IS, assessed by the incidence of adverse events during iron replacement. The meta-analysis was performed using RevMan 5.3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We identified 9 RCTs with 910 patients (FCM group, n\u200a=\u200a456; IS group, n\u200a=\u200a454). Before iron replacement, FCM and IS group patients had similar baseline Hb (mean difference [MD], 0.04\u200ag\/dL; 95% confidence interval [CI], \u22120.07 to 015; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>\u200a=\u200a0%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.48) and ferritin levels (MD, \u22120.42\u200ang\/mL; 95% CI, \u22121.61 to 0.78; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>\u200a=\u200a45%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.49). Following iron replacement, patients who received FCM had higher Hb (MD, 0.67; 95% CI, 0.25\u20131.08; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>\u200a=\u200a92%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.002) and ferritin levels (MD, 24.41; 95% CI, 12.06\u201336.76; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>\u200a=\u200a75%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.0001) than patients who received IS. FCM group showed a lower incidence of adverse events following iron replacement than IS group (risk ratio, 0.53; 95% CI, 0.35\u20130.80; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>\u200a=\u200a0%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.003). Serious adverse events were not reported in any group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>FCM group showed better efficacy in increasing Hb and ferritin levels and a favorable safety profile with fewer adverse events compared with IS group for IDA treatment among obstetric and gynecologic patients. However, this meta-analysis was limited by the small number of RCTs and high heterogeneity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration:<\/jats:title>\n            <jats:p>The review was prospectively registered with the International Prospective Registry of Systematic Reviews (https:\/\/www.crd.york.ac.uk\/prospero\/, registration number CRD42019148905).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024571","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T15:09:37Z","timestamp":1621350577000},"page":"e24571","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":34,"title":["Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for iron deficiency anemia in obstetric and gynecologic patients"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3770-6675","authenticated-orcid":false,"given":"Hye Won","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Yeon","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Ji","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ji","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Sun","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Kyung","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/01443615.2016.1180505","article-title":"Iron deficiency anaemia in pregnancy: the role of parenteral iron","volume":"37","author":"Esen","year":"2017","journal-title":"J Obstet Gynaecol"},{"key":"R2-20250504","first-page":"164","article-title":"Review on iron and its importance for human health","volume":"19","author":"Abbaspour","year":"2014","journal-title":"J Res Med Sci"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/gut.2003.035758","article-title":"Iron, anaemia, and inflammatory bowel diseases","volume":"53","author":"Gasche","year":"2004","journal-title":"Gut"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3945\/ajcn.110.007195","article-title":"Assessment of iron status in US pregnant women from the National Health and Nutrition Examination Survey (NHANES), 1999-2006","volume":"93","author":"Mei","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2796.2010.02251.x","article-title":"A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy","volume":"268","author":"Khalafallah","year":"2010","journal-title":"J Intern Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e75540","DOI":"10.1371\/journal.pone.0075540","article-title":"Treatment of anemia in inflammatory bowel disease\u2014systematic review and meta-analysis","volume":"8","author":"Avni","year":"2013","journal-title":"PLoS One"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5152\/jtgga.2015.15071","article-title":"Prevalence and risk factors of anemia among pregnant women attending a high-volume tertiary care center for delivery","volume":"16","author":"Taner","year":"2015","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/apt.14043","article-title":"Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease","volume":"45","author":"Aksan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajo.12695","article-title":"Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: a systematic review","volume":"58","author":"Qassim","year":"2018","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R11-20250504","first-page":"07","article-title":"A review on comparative study on safety and effectiveness of in ferric carboxy maltose versus iron sucrose in patients with iron deficiency anaemia of CKD","author":"Manju","year":"2019","journal-title":"Int J Pharmaceutical Chemical Biol Sci"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10198-013-0533-9","article-title":"Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data","volume":"15","author":"Brock","year":"2014","journal-title":"Eur J Health Econ"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"e0215427","DOI":"10.1371\/journal.pone.0215427","article-title":"Efficacy of perioperative intravenous iron therapy for transfusion in orthopedic surgery: a systematic review and meta-analysis","volume":"14","author":"Shin","year":"2019","journal-title":"PLoS One"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"The PRISMA statement: preferred reporting items for systematic reviews and metaanalyses","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/jog.13893","article-title":"Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: an open-label, multicenter, randomized study","volume":"45","author":"Lee","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12884-019-2200-3","article-title":"Comparison of ferric carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy\u2014randomised controlled trial","volume":"19","author":"Jose","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"06","DOI":"10.1186\/s12905-017-0506-8","article-title":"Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials","volume":"18","author":"Naqash","year":"2018","journal-title":"BMC Womens Health"},{"key":"R19-20250504","first-page":"91","article-title":"Comparative study of intravenous ferric carboxymaltose and iron sucrose in the management of postnatal iron deficiency anaemia","volume":"6","author":"Sumathy","year":"2017","journal-title":"Ind J Res"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijgo.2015.09.007","article-title":"Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding","volume":"133","author":"Mahey","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.18203\/2320-1770.ijrcog20162199","article-title":"Comparative study of efficacy and safety of intravenous ferric carboxy maltose versus iron sucrose in treatment of postpartum iron deficiency anemia","volume":"5","author":"Joshi","year":"2016","journal-title":"Int J Reprod Contraception Obstetr Gynecol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"669","DOI":"10.18203\/2320-1770.ijrcog20150071","article-title":"Comparative study of intravenous iron sucrose versus ferric carboxymaltose for the treatment of iron deficiency anemia in postpartum patients","volume":"4","author":"Hol","year":"2015","journal-title":"Int J Reprod Contraception Obstetr Gynecol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5005\/jp-journals-10006-1314","article-title":"A comparative study to evaluate the efficacy and safety of single dose intravenous iron carboxymaltose vs multidose iron sucrose in postpartum cases of severe iron deficiency anemia","volume":"7","author":"Garg","year":"2015","journal-title":"J South Asian Federation Obstetr Gynaecol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/2229-516X.149230","article-title":"Ferric carboxymaltose: a revolution in the treatment of postpartum anemia in Indian women","volume":"5","author":"Rathod","year":"2015","journal-title":"Int J Appl Basic Med Res"},{"key":"R25-20250504","first-page":"301","article-title":"Intravenous iron-dextran: therapeutic and experimental possibilities","volume":"100","author":"Ganzoni","year":"1970","journal-title":"Schweiz Med Wochenschr"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"763576","DOI":"10.1155\/2015\/763576","article-title":"Intravenous iron therapy in patients with iron deficiency anemia: dosing considerations","volume":"2015","author":"Koch","year":"2015","journal-title":"Anemia"},{"key":"R27-20250504","first-page":"01","article-title":"Recommendations to prevent and control iron deficiency in the United States","volume":"47","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1401038","article-title":"Iron-deficiency anemia","volume":"372","author":"Camaschella","year":"2015","journal-title":"N Engl J Med"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jp.2017.43","article-title":"Iron supplementation in singleton pregnancy: is there a benefit to doubling the dose of elemental iron in iron-deficient pregnant women? A randomized controlled trial","volume":"37","author":"Shinar","year":"2017","journal-title":"J Perinatol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2015-05-642223","article-title":"Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women","volume":"126","author":"Moretti","year":"2015","journal-title":"Blood"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/tme.12443","article-title":"Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement","volume":"28","author":"Mu\u00f1oz","year":"2018","journal-title":"Transfus Med"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2146\/ajhp110262","article-title":"Comparison of rates of reported adverse events associated with i.v. iron products in the United States","volume":"69","author":"Bailie","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"R34-20250504","first-page":"386","article-title":"Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications","volume":"60","author":"Bailie","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"R35-20250504","first-page":"345","article-title":"The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose","volume":"60","author":"Funk","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.gastro.2011.06.005","article-title":"FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease","volume":"141","author":"Evstatiev","year":"2011","journal-title":"Gastroenterology"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00404-018-4782-9","article-title":"Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy","volume":"298","author":"Froessler","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijgo.2007.10.009","article-title":"Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia","volume":"101","author":"Breymann","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000275286.03283.18","article-title":"Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial","volume":"110","author":"Van Wyck","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R41-20250504","first-page":"49","article-title":"Severe hypophosphataemia after intravenous iron administration","volume":"72","author":"Blazevic","year":"2014","journal-title":"Neth J Med"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J Bone Miner Res"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1537-2995.2009.02327.x","article-title":"Blood management: large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial","volume":"49","author":"Van Wyck","year":"2009","journal-title":"Transfusion"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/ndt\/gfq613","article-title":"A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients","volume":"26","author":"Qunibi","year":"2011","journal-title":"Nephrol Dial Transplant"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:23:09Z","timestamp":1746339789000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024571"}},"subtitle":["A systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":41,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024571","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"2020-10-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}